Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 12:33 AM
Ignite Modification Date:
2025-12-25 @ 10:41 PM
NCT ID:
NCT02572167
Group ID:
EG001
Title:
Part 2: Staggered Dose Expansion
Description:
Brentuximab vedotin plus nivolumab; staggered dose in Cycle 1 only. brentuximab vedotin: 1.8 mg/kg by intravenous (IV) infusion for up to 4 cycles nivolumab: 3 mg/kg by intravenous (IV) infusion for up to 4 cycles
Deaths Number Affected:
8
Deaths Number At Risk:
None
Serious Number Affected:
16
Serious Number At Risk:
55
Other Number Affected:
55
Other Number At Risk:
55
Study:
NCT02572167
Results Section:
NCT02572167
Adverse Events Module:
NCT02572167